Latest news
Loading news…
Veloxis
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Hørsholm, Hovedstaden, Denmark Founded 2002 101-250 employees For Profit
Veloxis is a speciality pharmaceutical company focused on the development and commercialization of Envarsus.
Veloxis on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Veloxis was acquired by Asahi Kasei in 2019 for $1.3B.
Total Funding
$60M
Funding Rounds
1
Last Funding
Acquisitions
1
Investments
1
Monthly Visits
Contacts
89
Patents
7
About Veloxis
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- VELO
- Exchange
- NASDAQ
- IPO date
- Nov 13, 2006
- Delisted
- Feb 24, 2020
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 17
- Active products
- 21
- Patents granted
- 7
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $855.44K
Investor Activity
- Investments
- 1
- Lead investments
- 1
- Portfolio orgs
- 1
Company Info
- Founded
- 2002
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- News articles
- 38
- HQ
- Hørsholm, Hovedstaden, Denmark
- Region
- European Union (EU), Nordic Countries, Scandinavia
- Exit date
- Nov 13, 2006
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 1.3
- Trend (90d)
- -0.2
Veloxis Funding Rounds
1 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–1 of 1Show
Page 1 / 1
Veloxis Investments
Loading columns…
0 of 0Show
Page 1 / 1
Veloxis Acquisitions
1 results
| Acquiree Name | Acquirer Name | Acquisition Type | Acquisition Terms | Acquiree Industries | Acquiree Hq City | Acquiree Hq Country | Acquiree Description | Acquiree Number Of Employees | Acquirer Industries | Acquirer Hq Country | Acquirer Number Of Employees | Acquirer Ipo Status | Acquiree Website | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AiCuris | $921.49M | 2026-02-26 | Veloxis | Acquisition | Cash | BiotechnologyHealth CareTherapeutics | Wuppertal | Germany | AiCuris is a pharmaceutical research company that focuses on… | 2006-01-01 | 51-100 | BiotechnologyHealth CareMedicalPharmaceutical | Denmark | 101-250 | Delisted | 1 | www.aicuris.com |
1–1 of 1Show
Page 1 / 1
Veloxis Key People
President, CEO
Chief Scientific Officer
SVP, Global Clinical Development & Operations
89
professional contacts at Veloxis
Contact execs at Veloxis →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Veloxis
Loading news…
FAQs about Veloxis
People who checked this page also checked these
Sectors Veloxis invests & acquires in
Browse the full Acquirezy directory.